D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 34,643 473 World Ranking 8945 National Ranking 4773

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

His scientific interests lie mostly in Prostate cancer, Internal medicine, Gynecology, Prostatectomy and Surgery. David F. Penson has included themes like Odds ratio, Prostate and Radiation therapy in his Prostate cancer study. His biological study spans a wide range of topics, including Oncology and Risk assessment.

His Gynecology research incorporates elements of Cancer, Epidemiology, Incidence, Confidence interval and Risk factor. His studies in Prostatectomy integrate themes in fields like Urinary incontinence, Urology, Sexual function, Erectile dysfunction and Cohort. His Surgery research incorporates themes from Bladder cancer and Cystectomy.

His most cited work include:

  • Sipuleucel-T immunotherapy for castration-resistant prostate cancer. (3775 citations)
  • Early detection of prostate cancer: AUA Guideline (797 citations)
  • Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends (792 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Surgery and Urology. The study incorporates disciplines such as Gynecology and Prostate in addition to Prostate cancer. His Gynecology research includes themes of Odds ratio, Epidemiology, Confidence interval and Comorbidity.

His research in Oncology intersects with topics in Castration resistant and Enzalutamide. His study in Surgery is interdisciplinary in nature, drawing from both Bladder cancer and Cystectomy. His Prostatectomy research is multidisciplinary, relying on both Radiation therapy and Sexual function.

He most often published in these fields:

  • Prostate cancer (50.12%)
  • Internal medicine (45.60%)
  • Oncology (26.62%)

What were the highlights of his more recent work (between 2016-2021)?

  • Prostate cancer (50.12%)
  • Internal medicine (45.60%)
  • Oncology (26.62%)

In recent papers he was focusing on the following fields of study:

David F. Penson mainly focuses on Prostate cancer, Internal medicine, Oncology, MEDLINE and Cancer. David F. Penson interconnects Radiation therapy, Radiology and Prostate in the investigation of issues within Prostate cancer. His work on Enzalutamide, Cohort study, Androgen deprivation therapy and Quality of life as part of general Internal medicine research is frequently linked to In patient, bridging the gap between disciplines.

The various areas that David F. Penson examines in his Oncology study include Randomized controlled trial, Gynecology and Prostate cancer screening. The concepts of his Cancer study are interwoven with issues in Malignancy and Cohort. His Prostatectomy research focuses on Sexual function and how it relates to Urinary incontinence.

Between 2016 and 2021, his most popular works were:

  • Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology (544 citations)
  • Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years (155 citations)
  • Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years (155 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

David F. Penson mostly deals with Prostate cancer, Internal medicine, Oncology, Prostatectomy and Cohort study. His Prostate cancer study integrates concerns from other disciplines, such as Radiation therapy and Urology. When carried out as part of a general Internal medicine research project, his work on Enzalutamide, Cohort, Randomized controlled trial and Androgen deprivation therapy is frequently linked to work in African american, therefore connecting diverse disciplines of study.

The Prostatectomy study combines topics in areas such as Interpretation, Quality of life, Sexual function, Prospective cohort study and Urinary incontinence. His work deals with themes such as Odds, Ethnic group and Proportional hazards model, which intersect with Cohort study. David F. Penson combines subjects such as Gynecology and Risk assessment with his study of Prostate-specific antigen.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Philip W. Kantoff;Celestia S. Higano;Neal D. Shore;E. Roy Berger.
The New England Journal of Medicine (2010)

5270 Citations

Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

Kevin T. McVary;Claus G. Roehrborn;Andrew L. Avins;Michael J. Barry.
The Journal of Urology (2011)

1246 Citations

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

Ruth Etzioni;David F. Penson;Julie M. Legler;Dante di Tommaso.
Journal of the National Cancer Institute (2002)

1232 Citations

Early detection of prostate cancer: AUA Guideline

H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni.
The Journal of Urology (2013)

1082 Citations

Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer

Matthew J. Resnick;Tatsuki Koyama;Kang-Hsien Fan;Peter C. Albertsen.
The New England Journal of Medicine (2013)

868 Citations

Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study

Arnold L. Potosky;William W. Davis;Richard M. Hoffman;Janet L. Stanford.
Journal of the National Cancer Institute (2004)

757 Citations

Epidemiology and cost of ventral hernia repair: making the case for hernia research

B. K. Poulose;J. Shelton;S. Phillips;D. Moore.
Hernia (2012)

737 Citations

5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.

David F. Penson;Dale McLerran;Ziding Feng;Lin Li.
The Journal of Urology (2005)

684 Citations

Overdiagnosis and Overtreatment of Prostate Cancer

Stacy Loeb;Marc A. Bjurlin;Joseph Nicholson;Teuvo L. Tammela.
European Urology (2014)

670 Citations

Prostate Cancer, Version 1.2016

James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico.
Journal of The National Comprehensive Cancer Network (2016)

589 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David F. Penson

Quoc-Dien Trinh

Quoc-Dien Trinh

Brigham and Women's Hospital

Publications: 134

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 132

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 121

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 120

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 117

Paul L. Nguyen

Paul L. Nguyen

Brigham and Women's Hospital

Publications: 115

Matthew R. Cooperberg

Matthew R. Cooperberg

University of California, San Francisco

Publications: 115

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 113

Fred Saad

Fred Saad

University of Montreal

Publications: 103

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 103

Mark S. Litwin

Mark S. Litwin

University of California, Los Angeles

Publications: 85

Johann S. de Bono

Johann S. de Bono

Institute of Cancer Research

Publications: 85

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 84

Adam S. Kibel

Adam S. Kibel

Brigham and Women's Hospital

Publications: 78

Monique J. Roobol

Monique J. Roobol

Erasmus MC

Publications: 73

Ian M. Thompson

Ian M. Thompson

The University of Texas Health Science Center at San Antonio

Publications: 73

Trending Scientists

Haralampos N. Miras

Haralampos N. Miras

University of Glasgow

Xiaoyan Jing

Xiaoyan Jing

Harbin Engineering University

Gang Sha

Gang Sha

Nanjing University of Science and Technology

Christian L. Lorson

Christian L. Lorson

University of Missouri

Joe Lutkenhaus

Joe Lutkenhaus

University of Kansas

Michael Wilkinson

Michael Wilkinson

Aberystwyth University

Richard D. Norris

Richard D. Norris

University of California, San Diego

Martin Jung

Martin Jung

Max Planck Society

Jianfeng Feng

Jianfeng Feng

Fudan University

J. J. Van Rood

J. J. Van Rood

Leiden University

Richard P. Phipps

Richard P. Phipps

University of Rochester

Katherine D. Kinzler

Katherine D. Kinzler

University of Chicago

Neil M. Ferguson

Neil M. Ferguson

Imperial College London

Ellen E. Blaak

Ellen E. Blaak

Maastricht University

Didier Payen

Didier Payen

Université Paris Cité

Graham Leslie Bradley

Graham Leslie Bradley

Griffith University

Something went wrong. Please try again later.